[Federal Register Volume 86, Number 57 (Friday, March 26, 2021)]
[Notices]
[Pages 16214-16215]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06288]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-21-21AT]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled Evaluation of Venous Thromboembolism 
Prevention Practices in U.S. Hospitals to the Office of Management and 
Budget (OMB) for review and approval. CDC previously published a 
``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on November 19, 2020 to obtain comments from 
the public and affected agencies. CDC did not receive comments related 
to the previous notice. This notice serves to allow an additional 30 
days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Evaluation of Venous Thromboembolism Prevention Practices in U.S. 
Hospitals--New--National Center on Birth Defects and Developmental 
Disabilities (NCBDDD), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    The National Center on Birth Defects and Disabilities (NCBDDD) is 
submitting a New Information Collection Request for one-year approval. 
Venous thromboembolism (VTE) is an important and growing public health 
problem. Over half of VTE events are associated with recent 
hospitalization and most occur after discharge. Hospital-associated VTE 
is often preventable but VTE prevention strategies are not applied 
uniformly or systematically across U.S. hospitals. The framework for 
VTE prevention in hospitalized patients includes a hospital VTE 
prevention policy, an interdisciplinary VTE team, a VTE prevention 
protocol, monitoring of processes and outcomes, and VTE prevention 
education for providers and patients. A VTE prevention protocol 
includes VTE risk assessment, bleeding risk assessment, and clinical 
decision support for appropriate VTE prophylaxis. Increase in VTE risk 
assessment rates have been associated with improvements in VTE 
prophylaxis.
    An implementation gap exists between evidence-based guidelines for 
VTE prophylaxis in hospitalized adult patients and implementation of 
those guidelines in real-world hospital settings. However, data on VTE 
prevention practices in U.S. hospitals is lacking. To address this gap, 
CDC, in collaboration with The Joint Commission, developed a survey on 
hospital VTE prevention practices. The survey will be implemented by 
The Joint Commission as an electronic one-time data collection in a 
nationally representative sample of U.S. adult general medical and 
surgical hospitals. The target respondent will be the

[[Page 16215]]

hospital Director of Patient Safety and Quality or similar position. 
The survey will be voluntary. No individual-level data will be 
collected. CDC will not receive any individual or hospital identifiable 
information.
    The information collected will improve understanding of hospital 
VTE prevention practices to guide efforts and inform interventions to 
reduce the burden of hospital-associated VTE. Information on the 
capacity of hospitals to collect data on VTE risk assessment will be 
helpful in determining the feasibility of VTE risk assessment as a VTE 
prevention performance measure. The data collected can also serve as a 
baseline for evaluation of future hospital-associated VTE prevention 
initiatives. The estimated annual burden is 384 hours, based on a pilot 
of the electronic survey at 9 hospitals. There is no cost to 
respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
The Director of Patient Safety and      Evaluation of Venous                 384               1               1
 Quality, the Chairperson of the         Thromboembolism
 Patient Safety Committee, other         Prevention Practices in
 quality improvement professional.       U.S. Hospitals
                                         Questionnaire.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-06288 Filed 3-25-21; 8:45 am]
BILLING CODE 4163-18-P